R--Intent to Sole Source in support of eImmune

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of Defense Health Clinical Systems (DHCS) Resource Management intends to issue a Firm-Fixed Price (FFP), Sole Source Award to Shoreland Inc. in accordance with statute 10 U.S.C. 2304(c)(1) as implemented under authority FAR 6.302-1, Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements. The Period of Performance for this proposed contract is for a period of twelve (12) months. This proposed contract action is to upgrade the functionality, reliability and accuracy of data exchanges between eImmune, an existing software application in use by White House Medical Unit (WHMU) and Travax, an internet accessible subscription-based and international travel medicine awareness Commercial Off-The-Shelf (COTS) solution. Specifically, the government will procure services to meet the following objectives: 1. Maintain existing interfaces and incorporate additional data required by the enterprise. 2. Upgrade additional standard queries, ad hoc query tools and business intelligence tools for decision support. 3. Functional and technical integration of eImmune-MedVisa and all associated net-centric functionalities to be brought in line with industry standards. 4. Upgrade the user interface and data access layer of eImmune from ASP to ASP.NET to continue to work with current browser technology. These systems were previously procured on a competitive basis. Shoreland Inc. is the sole developer of the Travax applications and owns the rights to the source code. In addition, Shoreland Inc. possesses all rights, title and interests of Travax and related publications to include its multinational collaborative database and Medical Visa. The North American Industry Classification System (NAICS) for this requirement is 541511 and the size standard is $25.5M. THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE QUOTES and a written solicitation will not be issued. This announcement constitutes the only notice by the government; however any interested small business that believes it can meet the requirement must respond in writing in the form of a capability statement. Responses must include supporting evidence that is clear and concise which articulates the ability to comply with the requirement outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose to determine whether a competitive procurement is in the best interest of the Government. A determination by the Government not to compete this procurement on a full and open competitive basis will be made based on the responses received. Determination is solely within the discretion of the Government. If no written responses are received by the date listed below, which reflects fifteen (15) days after the publication of this notice, the proposed contract will be awarded without further remark. Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than 5:00 pm EST, Thursday, July 31, 2014. All questions and responses concerning this notice shall be emailed to MAJ Georgeana Green at contact@example.gov. Contracting Office Address: US Army Medical Research Acquisition Activity ATTN: MCMR-AAA-SF 820 Chandler Street Frederick, MD 21702-5014 Point of Contact: MAJ Georgeana Green